Phospho-MAPKAPK2 (Ser272) Antibody

What is MAPKAPK2 and why is phosphorylation at Ser272 significant?

MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2, also known as MK2) is a serine/threonine protein kinase that is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, MAPKAPK2 is involved in numerous cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation, and cell proliferation .

The phosphorylation of MAPKAPK2 occurs at multiple sites, but four residues are particularly important: Thr25, Thr222, Ser272, and Thr334. These sites are phosphorylated by p38 MAPK in kinase assays . Specifically, phosphorylation at Thr222, Ser272, and Thr334 appears to be essential for the activation of MAPKAPK2 . Ser272 phosphorylation contributes to the full activation of the kinase and its downstream signaling capabilities.

What detection methods are compatible with Phospho-MAPKAPK2 (Ser272) Antibody?

Based on product specifications, Phospho-MAPKAPK2 (Ser272) Antibody is compatible with multiple detection methods:

• Western Blotting (WB): Typically used at dilutions of 1:500-1:1000

• Immunohistochemistry (IHC) on paraffin-embedded tissues: Recommended dilutions of 1:50-1:100

• ELISA (Enzyme-Linked Immunosorbent Assay): Optimal dilution range of 1:2000-1:10000

• Dot Blot: As specified in product documentation

The antibody has been validated for detection of endogenous levels of MAPKAPK2 protein specifically when phosphorylated at Ser272 .

What is the species reactivity profile of commercially available Phospho-MAPKAPK2 (Ser272) Antibodies?

The commercially available Phospho-MAPKAPK2 (Ser272) Antibodies generally demonstrate reactivity across several mammalian species:

• Human: Confirmed reactivity in human samples across multiple antibody providers

• Mouse: Validated cross-reactivity

• Rat: Validated cross-reactivity

Some products are additionally predicted to react with other species based on sequence homology, though experimental validation may be necessary before use in those systems. This broad species reactivity makes these antibodies versatile tools for comparative studies across mammalian models .

How should samples be prepared to maximize detection of phosphorylated MAPKAPK2 at Ser272?

For optimal detection of phosphorylated MAPKAPK2 at Ser272, implement the following sample preparation guidelines:

• Stimulation conditions: UV irradiation is an effective stimulus to induce MAPKAPK2 phosphorylation, as demonstrated in RAW264.7 cells . Exposure time of approximately 15 minutes has been validated.

• Lysis buffer composition: Use a complete lysis buffer with phosphatase inhibitors to prevent dephosphorylation. Avoid reagents that will denature the capture antibodies such as high concentrations of reducing agents (e.g., DTT) and ionic detergents (e.g., SDS) .

• Sample handling: Maintain samples on ice after lysis until analysis to preserve phosphorylation status.

• Positive controls: Include lysates from cells treated with known activators of the p38 MAPK pathway, such as calyculin A (50 nM, 30 minutes) .

• Negative controls: Use unstimulated cells or cells treated with inhibitors of the p38 MAPK pathway as negative controls.

For assay validation, always include a phospho-blocking peptide control to confirm antibody specificity, as demonstrated in Western blot and IHC analyses .

What are the optimal protocols for Western blot analysis using Phospho-MAPKAPK2 (Ser272) Antibody?

For optimal Western blot analysis with Phospho-MAPKAPK2 (Ser272) Antibody:

• Sample preparation:

  • Treat cells with appropriate stimuli (e.g., UV radiation for 15 minutes for RAW264.7 cells)

  • Prepare lysates using buffers containing phosphatase inhibitors

  • Quantify protein concentration for equal loading

• Gel electrophoresis and transfer:

  • Load 20 μg of protein per lane (as validated in previous studies)

  • Expected molecular weight: ~49 kDa (this may vary slightly between 45-52 kDa depending on phosphorylation state)

• Antibody incubation:

  • Primary antibody: Use at 1:500-1:1000 dilution in appropriate blocking buffer

  • Include negative controls and phospho-peptide competition controls

• Detection and validation:

  • Use appropriate secondary antibody and detection system

  • Always run phospho-peptide competition controls in parallel (treating antibody with the phospho-peptide before incubation) to confirm specificity of the signal

The specificity of the antibody signal can be confirmed by the absence of signal in the lane treated with the phospho-peptide competition control, as shown in Western blot analyses of RAW264.7 cell extracts .

How can Phospho-MAPKAPK2 (Ser272) be evaluated in tissue sections using immunohistochemistry?

For successful immunohistochemical analysis of Phospho-MAPKAPK2 (Ser272) in tissue sections:

• Tissue preparation:

  • Use properly fixed, paraffin-embedded tissue sections (human brain tissue has been successfully used for validation)

  • Follow standard deparaffinization and antigen retrieval protocols

• Staining protocol:

  • Blocking: Block endogenous peroxidase activity and non-specific binding sites

  • Primary antibody: Apply Phospho-MAPKAPK2 (Ser272) antibody at 1:50-1:100 dilution

  • Detection: Use appropriate secondary antibody and visualization system

• Controls:

  • Positive control: Include tissues known to express phosphorylated MAPKAPK2

  • Negative control: Omit primary antibody

  • Specificity control: Pre-incubate antibody with phospho-peptide before application to tissue sections

• Analysis:

  • Compare staining patterns between test sections and controls

  • Verify specificity by confirming absence of staining in sections treated with antibody pre-incubated with phospho-peptide

Published immunohistochemical analyses demonstrate clear staining in human brain tissue using Phospho-MAPKAPK2 (Ser272) antibody, with complete blocking of the signal when the antibody is pre-incubated with the phospho-peptide .

How does MAPKAPK2 phosphorylation at Ser272 compare functionally with phosphorylation at other sites (Thr222, Thr334)?

MAPKAPK2 phosphorylation occurs at multiple sites with distinct functional implications:

• Comparative importance of phosphorylation sites:

  • Thr222, Ser272, and Thr334 phosphorylation appears essential for full MAPKAPK2 activity

  • Thr25 is phosphorylated by p42 MAPK in vitro but is not required for activation

• Site-specific functions:

  • Thr334 phosphorylation: Commonly used as a marker of MAPKAPK2 activation; phosphorylation at this site can be detected in response to stress stimuli

  • Thr222 phosphorylation: Located in the activation loop and directly affects catalytic activity

  • Ser272 phosphorylation: Contributes to full activation but may have additional regulatory functions

• Signaling pathway interactions:

  • While p38 MAPK primarily phosphorylates these sites, there may be cross-talk with other pathways

  • Different phosphorylation patterns may affect substrate specificity or subcellular localization

Understanding the precise contribution of Ser272 phosphorylation relative to other sites requires multi-site mutational analysis and comparative phospho-specific antibody studies.

What is the relationship between p38 MAPK and MAPKAPK2 phosphorylation, and how can this be experimentally manipulated?

The p38 MAPK and MAPKAPK2 relationship represents a critical signaling node that can be experimentally manipulated:

• Activation cascade:

  • p38 MAPK is activated by upstream MAPKKs (MEK3/6) in response to stress stimuli

  • Activated p38 MAPK directly phosphorylates MAPKAPK2 at Thr222, Ser272, and Thr334

  • p38α appears to be stably associated with MAPKAPK2 and is ubiquitously expressed, with highest levels in leukocytes, liver, spleen, bone marrow, thyroid, and placenta

• Experimental manipulation:

  • Pharmacological activation: Treatment with calyculin A (50 nM, 30 minutes) can induce phosphorylation

  • Stress induction: UV irradiation (15 minutes), osmotic shock, heat shock, and inflammatory cytokines activate the pathway

  • Inhibition approaches: MEK1/2 inhibitors like PD98059, U0126, PD184352, and PD0325901 can block upstream activation

  • Negative control treatments: Rapamycin (1 μM, 3 hours) has been used as a negative control for p38 MAPK/MAPKAPK2 activation

• Functional readouts:

  • MAPKAPK2 kinase activity assays using known substrates like HSP27

  • Nuclear-cytoplasmic translocation of the p38α/MAPKAPK2 complex following activation

  • Downstream phosphorylation events such as Cdc25 B/C

These experimental approaches allow detailed investigation of the p38 MAPK/MAPKAPK2 signaling axis in various cellular contexts.

How does MAPKAPK2 phosphorylation affect crosstalk between the p38 MAPK and cAMP signaling pathways?

MAPKAPK2 phosphorylation creates an important node for crosstalk between the p38 MAPK and cAMP signaling pathways:

• MAPKAPK2 phosphorylation of PDE4A5:

  • MAPKAPK2 (MK2) phosphorylates cAMP-specific PDE4A5 (phosphodiesterase-4A5) at Ser147 within the regulatory UCR1 domain

  • This phosphorylation doesn't alter PDE4A5 activity directly but markedly attenuates PDE4A5 activation through subsequent phosphorylation by protein kinase A (PKA)

• Functional consequences:

  • This modification amplifies intracellular cAMP accumulation by attenuating a major cAMP desensitization system

  • The effect is observed in wild-type primary macrophages but not in MK2/3-null macrophages, confirming the physiological relevance

• Conformational changes and protein interactions:

  • Phosphorylation by MK2 triggers a conformational change in PDE4A5

  • This conformational change attenuates PDE4A5 interaction with proteins that bind via UCR2, such as DISC1 (disrupted in schizophrenia 1) and AIP (aryl hydrocarbon receptor-interacting protein)

  • Importantly, interactions with UCR2-independent binding partners like β-arrestin remain unaffected

This research demonstrates that MAPKAPK2 serves as a critical integration point between stress-activated p38 MAPK signaling and the cAMP pathway, potentially explaining how stress responses can modulate cAMP-dependent cellular processes.

What are common issues encountered when using Phospho-MAPKAPK2 (Ser272) Antibody and how can they be resolved?

Common issues and solutions when working with Phospho-MAPKAPK2 (Ser272) Antibody:

• Weak or absent signal:

  • Ensure adequate stimulation of the p38 MAPK pathway; use UV treatment (15 minutes) for positive controls

  • Verify inclusion of phosphatase inhibitors in lysis buffers

  • Optimize antibody concentration; try 1:500 dilution for Western blot if signal is weak at higher dilutions

  • Extend primary antibody incubation time or temperature

  • Ensure proper antigen retrieval for IHC applications

• Non-specific bands in Western blots:

  • Increase blocking time or concentration of blocking agent

  • Dilute primary antibody further (1:1000 instead of 1:500)

  • Run a phospho-peptide competition control in parallel to distinguish specific from non-specific bands

  • Use freshly prepared samples to minimize protein degradation

• Background staining in IHC:

  • Optimize blocking conditions

  • Reduce primary antibody concentration (try 1:100)

  • Extend washing steps

  • Include controls with phospho-peptide competition to verify specificity

• Inconsistent results between experiments:

  • Standardize cell stimulation protocols

  • Use consistent lysis buffer composition

  • Prepare aliquots of antibody to avoid freeze-thaw cycles

  • Store antibody at -20°C and avoid freeze-thaw cycles as specified in product information

Always include appropriate positive controls (UV-stimulated cells), negative controls, and phospho-peptide competition controls to validate results and troubleshoot issues.

How can researchers optimize sandwich immunoassays for phospho-MAPKAPK2 detection?

Optimizing sandwich immunoassays for phospho-MAPKAPK2 detection:

• Assay principle understanding:

  • Sandwich immunoassays for phospho-proteins utilize a capture antibody against the total protein and a detection antibody specific for the phosphorylated form

  • For MAPKAPK2, this involves anti-total MAPKAPK2 capture antibody and phospho-specific detection antibody (e.g., anti-phospho-MAPKAPK2 Ser272)

• Sample preparation optimization:

  • Use complete lysis buffer with phosphatase inhibitors

  • Avoid reagents that denature capture antibodies (high concentrations of reducing agents like DTT should be avoided, as should SDS and other ionic detergents)

  • Block plates thoroughly with appropriate blocking solution (150 μL per well for 1 hour at room temperature with vigorous shaking at 300-1000 rpm)

• Protocol optimization:

  • Washing: Perform 3 wash steps with 300 μL/well of appropriate wash buffer

  • Sample volume: Use 25 μL/well of sample and incubate with vigorous shaking (300-1000 rpm) for 1 hour

  • Detection antibody: Use 25 μL/well of 1X detection antibody solution and incubate with vigorous shaking for 1 hour

  • Reading: Add 150 μL/well read buffer and analyze within 5 minutes

• Controls and standards:

  • Include a titration series of positive control lysates (e.g., from cells treated with calyculin A)

  • Include negative control lysates (e.g., from cells treated with rapamycin)

  • Create standard curves using validated reference materials

For electrochemiluminescence-based platforms like MSD, signal intensity directly correlates with the amount of phosphorylated MAPKAPK2 present in samples, providing a quantitative measure comparable to traditional Western blots but with higher sensitivity and throughput .

What is the role of MAPKAPK2 and its phosphorylation at Ser272 in stress and inflammatory responses?

MAPKAPK2 and its phosphorylation at Ser272 play critical roles in stress and inflammatory responses:

• Activation in response to stress stimuli:

  • MAPKAPK2 is activated via phosphorylation by p38 MAPK in response to various stresses: heat shock, osmotic shock, radiation, reactive oxygen species, cytokines, and DNA damage

  • The p38α MAPK isoform appears to be stably associated with MAPKAPK2 and is ubiquitously expressed with highest levels in leukocytes, liver, spleen, bone marrow, thyroid, and placenta

  • Phosphorylation at Ser272, along with Thr222 and Thr334, is essential for full activation of MAPKAPK2

• Downstream effectors and biological outcomes:

  • Heat shock protein HSP27 is a well-characterized substrate of MAPKAPK2 in vivo

  • In response to UV irradiation, activated p38α/MAPKAPK2 can translocate to the nucleus and directly phosphorylate Cdc25 B/C, generating a 14-3-3 protein binding site

  • MAPKAPK2 regulates inflammatory gene expression through post-transcriptional mechanisms including mRNA stability and translation

• Inflammatory signaling integration:

  • MAPKAPK2 serves as a critical node in inflammatory signaling networks

  • Its activation contributes to the production of pro-inflammatory cytokines

  • The importance of this pathway is demonstrated by the fact that PDE4 selective inhibitors (which interact with MAPKAPK2-regulated pathways) exert profound anti-inflammatory effects

Understanding MAPKAPK2 phosphorylation at Ser272 provides insight into how cells integrate and respond to diverse stress signals, making it a potential therapeutic target for inflammatory and stress-related disorders.

How does MAPKAPK2 phosphorylation status relate to potential therapeutic applications?

MAPKAPK2 phosphorylation status has significant implications for therapeutic development:

• Therapeutic targeting approaches:

  • Direct inhibition of MAPKAPK2 may provide more specific anti-inflammatory effects compared to upstream p38 MAPK inhibitors

  • The p38 MAPK pathway inhibitors (like PD98059, U0126, PD184352, and PD0325901) have been developed and entered clinical trials as potential anticancer agents

  • PDE4 selective inhibitors, which interact with pathways regulated by MAPKAPK2, exert profound anti-inflammatory effects and act as cognitive enhancers

• Disease relevance and biomarker potential:

  • MAPKAPK2 phosphorylation could serve as a biomarker for p38 MAPK pathway activation in various diseases

  • The pathway is implicated in inflammatory disorders, stress responses, and certain cancers

  • Phospho-specific antibodies against MAPKAPK2 Ser272 enable monitoring of pathway activation in clinical samples and during drug treatment

• Cross-pathway modulation:

  • The finding that MAPKAPK2 phosphorylation of PDE4A5 attenuates its activation by PKA reveals a mechanism for amplifying cAMP signaling during stress

  • This cross-pathway modulation offers potential therapeutic strategies for diseases where both stress responses and cAMP signaling are dysregulated

  • Understanding how MAPKAPK2 phosphorylation affects downstream substrates and pathways helps identify new therapeutic targets

Monitoring MAPKAPK2 phosphorylation status at Ser272 and other sites provides valuable insights for drug development strategies targeting the p38 MAPK pathway and its intersection with other signaling networks.

What are the emerging techniques and future directions for studying MAPKAPK2 phosphorylation in complex biological systems?

Emerging techniques and future research directions for MAPKAPK2 phosphorylation studies:

• Advanced phosphoproteomic approaches:

  • Mass spectrometry-based quantitative phosphoproteomics to simultaneously monitor multiple phosphorylation sites on MAPKAPK2 and its substrates

  • Phospho-flow cytometry for single-cell analysis of MAPKAPK2 activation in heterogeneous cell populations

  • Proximity ligation assays to detect in situ interactions between phosphorylated MAPKAPK2 and its binding partners

• Spatiotemporal dynamics visualization:

  • FRET-based biosensors to monitor MAPKAPK2 phosphorylation and conformational changes in live cells

  • Optogenetic tools to control p38 MAPK activation with spatiotemporal precision

  • Super-resolution microscopy to track phosphorylated MAPKAPK2 subcellular localization during cellular responses

• Systems biology integration:

  • Computational modeling of the p38 MAPK/MAPKAPK2 signaling network to predict pathway behavior under various conditions

  • Multi-omics approaches combining phosphoproteomics with transcriptomics and metabolomics to comprehensively map MAPKAPK2-dependent cellular responses

  • Network analysis to identify central nodes and feedback mechanisms in MAPKAPK2 signaling

• Translational applications:

  • Development of high-throughput screening platforms using phospho-specific antibodies to identify novel modulators of MAPKAPK2 activity

  • Implementation of phospho-MAPKAPK2 detection in precision medicine approaches for patient stratification

  • Application of phospho-MAPKAPK2 assays in drug development pipelines for compounds targeting stress and inflammatory pathways